nodes	percent_of_prediction	percent_of_DWPC	metapath
Acamprosate—GABRA1—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.000538	0.00241	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—SHH—pancreatic cancer	0.000536	0.0024	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—NRP1—pancreatic cancer	0.000532	0.00238	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—HIF1A—pancreatic cancer	0.000531	0.00238	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—IAPP—pancreatic cancer	0.00053	0.00237	CbGpPWpGaD
Acamprosate—Syncope—Docetaxel—pancreatic cancer	0.000529	0.000682	CcSEcCtD
Acamprosate—Dysphagia—Doxorubicin—pancreatic cancer	0.000529	0.000681	CcSEcCtD
Acamprosate—Asthma—Doxorubicin—pancreatic cancer	0.000529	0.000681	CcSEcCtD
Acamprosate—Influenza—Doxorubicin—pancreatic cancer	0.000529	0.000681	CcSEcCtD
Acamprosate—Leukopenia—Docetaxel—pancreatic cancer	0.000528	0.00068	CcSEcCtD
Acamprosate—Pollakiuria—Epirubicin—pancreatic cancer	0.000528	0.00068	CcSEcCtD
Acamprosate—Body temperature increased—Fluorouracil—pancreatic cancer	0.000528	0.000679	CcSEcCtD
Acamprosate—Eosinophilia—Doxorubicin—pancreatic cancer	0.000523	0.000674	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—SSTR3—pancreatic cancer	0.000523	0.00234	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—DTX1—pancreatic cancer	0.000523	0.00234	CbGpPWpGaD
Acamprosate—Palpitations—Docetaxel—pancreatic cancer	0.000522	0.000672	CcSEcCtD
Acamprosate—Photosensitivity reaction—Epirubicin—pancreatic cancer	0.000521	0.000671	CcSEcCtD
Acamprosate—Weight increased—Epirubicin—pancreatic cancer	0.00052	0.000669	CcSEcCtD
Acamprosate—Loss of consciousness—Docetaxel—pancreatic cancer	0.000519	0.000668	CcSEcCtD
Acamprosate—Pancreatitis—Doxorubicin—pancreatic cancer	0.000518	0.000667	CcSEcCtD
Acamprosate—Weight decreased—Epirubicin—pancreatic cancer	0.000517	0.000666	CcSEcCtD
Acamprosate—Hyperglycaemia—Epirubicin—pancreatic cancer	0.000515	0.000664	CcSEcCtD
Acamprosate—GRIN1—BDNF signaling pathway—NFKBIA—pancreatic cancer	0.000515	0.00231	CbGpPWpGaD
Acamprosate—Cough—Docetaxel—pancreatic cancer	0.000515	0.000663	CcSEcCtD
Acamprosate—Angina pectoris—Doxorubicin—pancreatic cancer	0.000515	0.000663	CcSEcCtD
Acamprosate—Hypersensitivity—Irinotecan—pancreatic cancer	0.000513	0.000661	CcSEcCtD
Acamprosate—Pneumonia—Epirubicin—pancreatic cancer	0.000512	0.00066	CcSEcCtD
Acamprosate—GRM5—GPCR downstream signaling—SST—pancreatic cancer	0.000512	0.00229	CbGpPWpGaD
Acamprosate—Convulsion—Docetaxel—pancreatic cancer	0.000511	0.000658	CcSEcCtD
Acamprosate—Hypertension—Docetaxel—pancreatic cancer	0.00051	0.000656	CcSEcCtD
Acamprosate—GRIN2D—Alzheimers Disease—TP53—pancreatic cancer	0.000509	0.00228	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—PTHLH—pancreatic cancer	0.000508	0.00228	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—PTCH1—pancreatic cancer	0.000508	0.00228	CbGpPWpGaD
Acamprosate—Bronchitis—Doxorubicin—pancreatic cancer	0.000508	0.000655	CcSEcCtD
Acamprosate—Myalgia—Docetaxel—pancreatic cancer	0.000502	0.000647	CcSEcCtD
Acamprosate—Chest pain—Docetaxel—pancreatic cancer	0.000502	0.000647	CcSEcCtD
Acamprosate—Arthralgia—Docetaxel—pancreatic cancer	0.000502	0.000647	CcSEcCtD
Acamprosate—Nausea—Sunitinib—pancreatic cancer	0.000502	0.000647	CcSEcCtD
Acamprosate—GRIN2B—BDNF signaling pathway—NFKBIA—pancreatic cancer	0.000502	0.00225	CbGpPWpGaD
Acamprosate—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—pancreatic cancer	0.000502	0.00225	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—SSTR1—pancreatic cancer	0.000501	0.00224	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—SST—pancreatic cancer	0.000501	0.00224	CbGpPWpGaD
Acamprosate—Asthenia—Irinotecan—pancreatic cancer	0.0005	0.000644	CcSEcCtD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000499	0.000643	CcSEcCtD
Acamprosate—Stomatitis—Epirubicin—pancreatic cancer	0.000497	0.000639	CcSEcCtD
Acamprosate—Urinary tract infection—Epirubicin—pancreatic cancer	0.000495	0.000638	CcSEcCtD
Acamprosate—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000492	0.000633	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—PPY—pancreatic cancer	0.000492	0.0022	CbGpPWpGaD
Acamprosate—Dry mouth—Docetaxel—pancreatic cancer	0.000491	0.000633	CcSEcCtD
Acamprosate—Sweating—Epirubicin—pancreatic cancer	0.000488	0.000629	CcSEcCtD
Acamprosate—Pollakiuria—Doxorubicin—pancreatic cancer	0.000488	0.000629	CcSEcCtD
Acamprosate—Asthenia—Gemcitabine—pancreatic cancer	0.000487	0.000627	CcSEcCtD
Acamprosate—Haematuria—Epirubicin—pancreatic cancer	0.000486	0.000625	CcSEcCtD
Acamprosate—Confusional state—Docetaxel—pancreatic cancer	0.000486	0.000625	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—SSTR2—pancreatic cancer	0.000483	0.00216	CbGpPWpGaD
Acamprosate—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.000483	0.000621	CcSEcCtD
Acamprosate—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000482	0.00062	CcSEcCtD
Acamprosate—Weight increased—Doxorubicin—pancreatic cancer	0.000481	0.000619	CcSEcCtD
Acamprosate—Epistaxis—Epirubicin—pancreatic cancer	0.00048	0.000619	CcSEcCtD
Acamprosate—Pruritus—Gemcitabine—pancreatic cancer	0.00048	0.000618	CcSEcCtD
Acamprosate—Infection—Docetaxel—pancreatic cancer	0.000479	0.000616	CcSEcCtD
Acamprosate—Weight decreased—Doxorubicin—pancreatic cancer	0.000478	0.000616	CcSEcCtD
Acamprosate—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000477	0.000614	CcSEcCtD
Acamprosate—Diarrhoea—Irinotecan—pancreatic cancer	0.000477	0.000614	CcSEcCtD
Acamprosate—Pneumonia—Doxorubicin—pancreatic cancer	0.000474	0.00061	CcSEcCtD
Acamprosate—GRIN2A—Alzheimers Disease—TNF—pancreatic cancer	0.000474	0.00212	CbGpPWpGaD
Acamprosate—Shock—Docetaxel—pancreatic cancer	0.000474	0.00061	CcSEcCtD
Acamprosate—GRM5—GPCR downstream signaling—CNR1—pancreatic cancer	0.000473	0.00212	CbGpPWpGaD
Acamprosate—Pruritus—Fluorouracil—pancreatic cancer	0.000472	0.000608	CcSEcCtD
Acamprosate—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000472	0.000607	CcSEcCtD
Acamprosate—Tachycardia—Docetaxel—pancreatic cancer	0.00047	0.000605	CcSEcCtD
Acamprosate—Skin disorder—Docetaxel—pancreatic cancer	0.000468	0.000602	CcSEcCtD
Acamprosate—GRIN1—EPH-Ephrin signaling—MMP9—pancreatic cancer	0.000468	0.00209	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CCKBR—pancreatic cancer	0.000466	0.00209	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—SST—pancreatic cancer	0.000465	0.00208	CbGpPWpGaD
Acamprosate—Diarrhoea—Gemcitabine—pancreatic cancer	0.000464	0.000598	CcSEcCtD
Acamprosate—Dizziness—Irinotecan—pancreatic cancer	0.000461	0.000593	CcSEcCtD
Acamprosate—Haemoglobin—Epirubicin—pancreatic cancer	0.00046	0.000592	CcSEcCtD
Acamprosate—Stomatitis—Doxorubicin—pancreatic cancer	0.000459	0.000592	CcSEcCtD
Acamprosate—Anorexia—Docetaxel—pancreatic cancer	0.000459	0.000591	CcSEcCtD
Acamprosate—Rhinitis—Epirubicin—pancreatic cancer	0.000458	0.00059	CcSEcCtD
Acamprosate—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000458	0.00059	CcSEcCtD
Acamprosate—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—pancreatic cancer	0.000458	0.00205	CbGpPWpGaD
Acamprosate—Hepatitis—Epirubicin—pancreatic cancer	0.000457	0.000589	CcSEcCtD
Acamprosate—Haemorrhage—Epirubicin—pancreatic cancer	0.000457	0.000589	CcSEcCtD
Acamprosate—Diarrhoea—Fluorouracil—pancreatic cancer	0.000457	0.000588	CcSEcCtD
Acamprosate—GRM5—GPCR downstream signaling—GCG—pancreatic cancer	0.000456	0.00204	CbGpPWpGaD
Acamprosate—GRIN2B—EPH-Ephrin signaling—MMP9—pancreatic cancer	0.000456	0.00204	CbGpPWpGaD
Acamprosate—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000455	0.000586	CcSEcCtD
Acamprosate—Pharyngitis—Epirubicin—pancreatic cancer	0.000454	0.000584	CcSEcCtD
Acamprosate—Sweating—Doxorubicin—pancreatic cancer	0.000452	0.000582	CcSEcCtD
Acamprosate—Oedema peripheral—Epirubicin—pancreatic cancer	0.00045	0.00058	CcSEcCtD
Acamprosate—Hypotension—Docetaxel—pancreatic cancer	0.00045	0.00058	CcSEcCtD
Acamprosate—Haematuria—Doxorubicin—pancreatic cancer	0.000449	0.000579	CcSEcCtD
Acamprosate—Epistaxis—Doxorubicin—pancreatic cancer	0.000445	0.000572	CcSEcCtD
Acamprosate—GRIN1—Spinal Cord Injury—PTGS2—pancreatic cancer	0.000444	0.00199	CbGpPWpGaD
Acamprosate—GRM5—G alpha (q) signalling events—PIK3CA—pancreatic cancer	0.000444	0.00199	CbGpPWpGaD
Acamprosate—Vomiting—Irinotecan—pancreatic cancer	0.000443	0.00057	CcSEcCtD
Acamprosate—Dizziness—Fluorouracil—pancreatic cancer	0.000441	0.000568	CcSEcCtD
Acamprosate—Visual impairment—Epirubicin—pancreatic cancer	0.000441	0.000567	CcSEcCtD
Acamprosate—Rash—Irinotecan—pancreatic cancer	0.000439	0.000566	CcSEcCtD
Acamprosate—Dermatitis—Irinotecan—pancreatic cancer	0.000439	0.000565	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000439	0.000565	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—GLI1—pancreatic cancer	0.000438	0.00196	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—DTX4—pancreatic cancer	0.000438	0.00196	CbGpPWpGaD
Acamprosate—Headache—Irinotecan—pancreatic cancer	0.000437	0.000562	CcSEcCtD
Acamprosate—Insomnia—Docetaxel—pancreatic cancer	0.000436	0.000561	CcSEcCtD
Acamprosate—GRM5—GPCR downstream signaling—AGTR1—pancreatic cancer	0.000435	0.00195	CbGpPWpGaD
Acamprosate—Paraesthesia—Docetaxel—pancreatic cancer	0.000433	0.000557	CcSEcCtD
Acamprosate—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—pancreatic cancer	0.000432	0.00193	CbGpPWpGaD
Acamprosate—Vomiting—Gemcitabine—pancreatic cancer	0.000432	0.000556	CcSEcCtD
Acamprosate—GRIN1—EPH-Ephrin signaling—SRC—pancreatic cancer	0.000431	0.00193	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—CXCL8—pancreatic cancer	0.000431	0.00193	CbGpPWpGaD
Acamprosate—Dyspnoea—Docetaxel—pancreatic cancer	0.000429	0.000553	CcSEcCtD
Acamprosate—GRM5—Signaling by GPCR—CNR1—pancreatic cancer	0.000429	0.00192	CbGpPWpGaD
Acamprosate—Somnolence—Docetaxel—pancreatic cancer	0.000428	0.000551	CcSEcCtD
Acamprosate—Rash—Gemcitabine—pancreatic cancer	0.000428	0.000551	CcSEcCtD
Acamprosate—Dermatitis—Gemcitabine—pancreatic cancer	0.000428	0.000551	CcSEcCtD
Acamprosate—Tinnitus—Epirubicin—pancreatic cancer	0.000426	0.000549	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—NRP1—pancreatic cancer	0.000426	0.00191	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PPP2R5B—pancreatic cancer	0.000426	0.00191	CbGpPWpGaD
Acamprosate—Haemoglobin—Doxorubicin—pancreatic cancer	0.000425	0.000548	CcSEcCtD
Acamprosate—Headache—Gemcitabine—pancreatic cancer	0.000425	0.000548	CcSEcCtD
Acamprosate—Vomiting—Fluorouracil—pancreatic cancer	0.000424	0.000546	CcSEcCtD
Acamprosate—Rhinitis—Doxorubicin—pancreatic cancer	0.000424	0.000546	CcSEcCtD
Acamprosate—Dyspepsia—Docetaxel—pancreatic cancer	0.000424	0.000546	CcSEcCtD
Acamprosate—Haemorrhage—Doxorubicin—pancreatic cancer	0.000423	0.000545	CcSEcCtD
Acamprosate—Hepatitis—Doxorubicin—pancreatic cancer	0.000423	0.000545	CcSEcCtD
Acamprosate—GRIN1—Developmental Biology—SLC2A2—pancreatic cancer	0.000422	0.00189	CbGpPWpGaD
Acamprosate—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000421	0.000542	CcSEcCtD
Acamprosate—Rash—Fluorouracil—pancreatic cancer	0.000421	0.000542	CcSEcCtD
Acamprosate—Dermatitis—Fluorouracil—pancreatic cancer	0.00042	0.000541	CcSEcCtD
Acamprosate—GRIN2B—EPH-Ephrin signaling—SRC—pancreatic cancer	0.00042	0.00188	CbGpPWpGaD
Acamprosate—Pharyngitis—Doxorubicin—pancreatic cancer	0.00042	0.000541	CcSEcCtD
Acamprosate—GRIN1—EPH-Ephrin signaling—VEGFA—pancreatic cancer	0.00042	0.00188	CbGpPWpGaD
Acamprosate—Decreased appetite—Docetaxel—pancreatic cancer	0.000419	0.000539	CcSEcCtD
Acamprosate—Headache—Fluorouracil—pancreatic cancer	0.000418	0.000538	CcSEcCtD
Acamprosate—GRIN2A—Alzheimers Disease—TP53—pancreatic cancer	0.000418	0.00187	CbGpPWpGaD
Acamprosate—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000417	0.000537	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000416	0.000535	CcSEcCtD
Acamprosate—GRM5—Signaling by GPCR—GCG—pancreatic cancer	0.000414	0.00186	CbGpPWpGaD
Acamprosate—Nausea—Irinotecan—pancreatic cancer	0.000414	0.000533	CcSEcCtD
Acamprosate—GRIN1—Alzheimers Disease—TNF—pancreatic cancer	0.000413	0.00185	CbGpPWpGaD
Acamprosate—Immune system disorder—Epirubicin—pancreatic cancer	0.000413	0.000532	CcSEcCtD
Acamprosate—GRIN1—Spinal Cord Injury—CASP3—pancreatic cancer	0.000412	0.00185	CbGpPWpGaD
Acamprosate—Constipation—Docetaxel—pancreatic cancer	0.000412	0.00053	CcSEcCtD
Acamprosate—Pain—Docetaxel—pancreatic cancer	0.000412	0.00053	CcSEcCtD
Acamprosate—GRIN2B—Developmental Biology—SLC2A2—pancreatic cancer	0.000412	0.00184	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—HEY2—pancreatic cancer	0.00041	0.00184	CbGpPWpGaD
Acamprosate—Chills—Epirubicin—pancreatic cancer	0.00041	0.000528	CcSEcCtD
Acamprosate—GRIN2B—EPH-Ephrin signaling—VEGFA—pancreatic cancer	0.000409	0.00183	CbGpPWpGaD
Acamprosate—Visual impairment—Doxorubicin—pancreatic cancer	0.000408	0.000525	CcSEcCtD
Acamprosate—Alopecia—Epirubicin—pancreatic cancer	0.000404	0.00052	CcSEcCtD
Acamprosate—Nausea—Gemcitabine—pancreatic cancer	0.000403	0.000519	CcSEcCtD
Acamprosate—GRIN2B—Alzheimers Disease—TNF—pancreatic cancer	0.000403	0.0018	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—CCND1—pancreatic cancer	0.000401	0.0018	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—GAST—pancreatic cancer	0.000401	0.00179	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—IAPP—pancreatic cancer	0.000401	0.00179	CbGpPWpGaD
Acamprosate—Mental disorder—Epirubicin—pancreatic cancer	0.000401	0.000516	CcSEcCtD
Acamprosate—Malnutrition—Epirubicin—pancreatic cancer	0.000398	0.000513	CcSEcCtD
Acamprosate—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—pancreatic cancer	0.000397	0.00178	CbGpPWpGaD
Acamprosate—Feeling abnormal—Docetaxel—pancreatic cancer	0.000397	0.000511	CcSEcCtD
Acamprosate—Nausea—Fluorouracil—pancreatic cancer	0.000396	0.00051	CcSEcCtD
Acamprosate—GRM5—Signaling by GPCR—AGTR1—pancreatic cancer	0.000395	0.00177	CbGpPWpGaD
Acamprosate—Tinnitus—Doxorubicin—pancreatic cancer	0.000394	0.000508	CcSEcCtD
Acamprosate—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000394	0.000507	CcSEcCtD
Acamprosate—Flatulence—Epirubicin—pancreatic cancer	0.000392	0.000505	CcSEcCtD
Acamprosate—GRIN2B—Developmental Biology—IAPP—pancreatic cancer	0.000391	0.00175	CbGpPWpGaD
Acamprosate—Tension—Epirubicin—pancreatic cancer	0.000391	0.000503	CcSEcCtD
Acamprosate—Dysgeusia—Epirubicin—pancreatic cancer	0.00039	0.000502	CcSEcCtD
Acamprosate—GRIN1—Spinal Cord Injury—MMP9—pancreatic cancer	0.00039	0.00174	CbGpPWpGaD
Acamprosate—Nervousness—Epirubicin—pancreatic cancer	0.000387	0.000498	CcSEcCtD
Acamprosate—Back pain—Epirubicin—pancreatic cancer	0.000385	0.000496	CcSEcCtD
Acamprosate—Muscle spasms—Epirubicin—pancreatic cancer	0.000383	0.000493	CcSEcCtD
Acamprosate—Immune system disorder—Doxorubicin—pancreatic cancer	0.000382	0.000492	CcSEcCtD
Acamprosate—Body temperature increased—Docetaxel—pancreatic cancer	0.000381	0.00049	CcSEcCtD
Acamprosate—Abdominal pain—Docetaxel—pancreatic cancer	0.000381	0.00049	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—HEY1—pancreatic cancer	0.00038	0.0017	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—SCT—pancreatic cancer	0.00038	0.0017	CbGpPWpGaD
Acamprosate—Chills—Doxorubicin—pancreatic cancer	0.00038	0.000489	CcSEcCtD
Acamprosate—Alopecia—Doxorubicin—pancreatic cancer	0.000374	0.000481	CcSEcCtD
Acamprosate—GABRB3—BDNF signaling pathway—TSC2—pancreatic cancer	0.000373	0.00167	CbGpPWpGaD
Acamprosate—Mental disorder—Doxorubicin—pancreatic cancer	0.000371	0.000477	CcSEcCtD
Acamprosate—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000369	0.000476	CcSEcCtD
Acamprosate—Malnutrition—Doxorubicin—pancreatic cancer	0.000368	0.000474	CcSEcCtD
Acamprosate—Anaemia—Epirubicin—pancreatic cancer	0.000368	0.000474	CcSEcCtD
Acamprosate—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—pancreatic cancer	0.000367	0.00164	CbGpPWpGaD
Acamprosate—Agitation—Epirubicin—pancreatic cancer	0.000366	0.000471	CcSEcCtD
Acamprosate—GRIN1—Alzheimers Disease—TP53—pancreatic cancer	0.000365	0.00163	CbGpPWpGaD
Acamprosate—Flatulence—Doxorubicin—pancreatic cancer	0.000363	0.000467	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—CCK—pancreatic cancer	0.000362	0.00162	CbGpPWpGaD
Acamprosate—Tension—Doxorubicin—pancreatic cancer	0.000361	0.000465	CcSEcCtD
Acamprosate—Dysgeusia—Doxorubicin—pancreatic cancer	0.000361	0.000464	CcSEcCtD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—HES1—pancreatic cancer	0.000359	0.00161	CbGpPWpGaD
Acamprosate—Malaise—Epirubicin—pancreatic cancer	0.000359	0.000462	CcSEcCtD
Acamprosate—Nervousness—Doxorubicin—pancreatic cancer	0.000358	0.000461	CcSEcCtD
Acamprosate—Vertigo—Epirubicin—pancreatic cancer	0.000358	0.000461	CcSEcCtD
Acamprosate—Syncope—Epirubicin—pancreatic cancer	0.000357	0.00046	CcSEcCtD
Acamprosate—Leukopenia—Epirubicin—pancreatic cancer	0.000356	0.000459	CcSEcCtD
Acamprosate—Back pain—Doxorubicin—pancreatic cancer	0.000356	0.000459	CcSEcCtD
Acamprosate—GRIN2B—Alzheimers Disease—TP53—pancreatic cancer	0.000355	0.00159	CbGpPWpGaD
Acamprosate—Hypersensitivity—Docetaxel—pancreatic cancer	0.000355	0.000457	CcSEcCtD
Acamprosate—Muscle spasms—Doxorubicin—pancreatic cancer	0.000354	0.000456	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—CNR2—pancreatic cancer	0.000353	0.00158	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—GLP1R—pancreatic cancer	0.000353	0.00158	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—CXCL8—pancreatic cancer	0.000353	0.00158	CbGpPWpGaD
Acamprosate—Palpitations—Epirubicin—pancreatic cancer	0.000352	0.000453	CcSEcCtD
Acamprosate—GRIN1—BDNF signaling pathway—CASP3—pancreatic cancer	0.000352	0.00157	CbGpPWpGaD
Acamprosate—Loss of consciousness—Epirubicin—pancreatic cancer	0.00035	0.000451	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—CCKAR—pancreatic cancer	0.000347	0.00156	CbGpPWpGaD
Acamprosate—Cough—Epirubicin—pancreatic cancer	0.000347	0.000447	CcSEcCtD
Acamprosate—Asthenia—Docetaxel—pancreatic cancer	0.000346	0.000445	CcSEcCtD
Acamprosate—Convulsion—Epirubicin—pancreatic cancer	0.000345	0.000444	CcSEcCtD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—CXCL8—pancreatic cancer	0.000345	0.00154	CbGpPWpGaD
Acamprosate—Hypertension—Epirubicin—pancreatic cancer	0.000344	0.000443	CcSEcCtD
Acamprosate—GRIN2B—BDNF signaling pathway—CASP3—pancreatic cancer	0.000343	0.00153	CbGpPWpGaD
Acamprosate—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000342	0.00044	CcSEcCtD
Acamprosate—Pruritus—Docetaxel—pancreatic cancer	0.000341	0.000439	CcSEcCtD
Acamprosate—Anaemia—Doxorubicin—pancreatic cancer	0.00034	0.000438	CcSEcCtD
Acamprosate—GABRB3—BDNF signaling pathway—NFKBIA—pancreatic cancer	0.00034	0.00152	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—CTNNB1—pancreatic cancer	0.000339	0.00152	CbGpPWpGaD
Acamprosate—Chest pain—Epirubicin—pancreatic cancer	0.000339	0.000436	CcSEcCtD
Acamprosate—Myalgia—Epirubicin—pancreatic cancer	0.000339	0.000436	CcSEcCtD
Acamprosate—Arthralgia—Epirubicin—pancreatic cancer	0.000339	0.000436	CcSEcCtD
Acamprosate—Agitation—Doxorubicin—pancreatic cancer	0.000338	0.000436	CcSEcCtD
Acamprosate—Anxiety—Epirubicin—pancreatic cancer	0.000338	0.000435	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—JAG2—pancreatic cancer	0.000337	0.00151	CbGpPWpGaD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000337	0.000433	CcSEcCtD
Acamprosate—Discomfort—Epirubicin—pancreatic cancer	0.000335	0.000431	CcSEcCtD
Acamprosate—Malaise—Doxorubicin—pancreatic cancer	0.000332	0.000428	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—MEN1—pancreatic cancer	0.000332	0.00149	CbGpPWpGaD
Acamprosate—Dry mouth—Epirubicin—pancreatic cancer	0.000331	0.000427	CcSEcCtD
Acamprosate—GRIN2C—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—pancreatic cancer	0.000331	0.00148	CbGpPWpGaD
Acamprosate—Vertigo—Doxorubicin—pancreatic cancer	0.000331	0.000426	CcSEcCtD
Acamprosate—GRIN2B—BDNF signaling pathway—CTNNB1—pancreatic cancer	0.00033	0.00148	CbGpPWpGaD
Acamprosate—Syncope—Doxorubicin—pancreatic cancer	0.00033	0.000425	CcSEcCtD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—CASP3—pancreatic cancer	0.00033	0.00148	CbGpPWpGaD
Acamprosate—Leukopenia—Doxorubicin—pancreatic cancer	0.00033	0.000425	CcSEcCtD
Acamprosate—Diarrhoea—Docetaxel—pancreatic cancer	0.00033	0.000424	CcSEcCtD
Acamprosate—Confusional state—Epirubicin—pancreatic cancer	0.000328	0.000422	CcSEcCtD
Acamprosate—Palpitations—Doxorubicin—pancreatic cancer	0.000325	0.000419	CcSEcCtD
Acamprosate—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000325	0.000418	CcSEcCtD
Acamprosate—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000324	0.000417	CcSEcCtD
Acamprosate—Infection—Epirubicin—pancreatic cancer	0.000323	0.000416	CcSEcCtD
Acamprosate—GRIN1—Spinal Cord Injury—MYC—pancreatic cancer	0.000322	0.00144	CbGpPWpGaD
Acamprosate—Cough—Doxorubicin—pancreatic cancer	0.000321	0.000414	CcSEcCtD
Acamprosate—GRIN1—Spinal Cord Injury—TGFB1—pancreatic cancer	0.000321	0.00144	CbGpPWpGaD
Acamprosate—Shock—Epirubicin—pancreatic cancer	0.00032	0.000412	CcSEcCtD
Acamprosate—Convulsion—Doxorubicin—pancreatic cancer	0.000319	0.000411	CcSEcCtD
Acamprosate—Dizziness—Docetaxel—pancreatic cancer	0.000319	0.00041	CcSEcCtD
Acamprosate—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000318	0.00041	CcSEcCtD
Acamprosate—Hypertension—Doxorubicin—pancreatic cancer	0.000318	0.000409	CcSEcCtD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—CTNNB1—pancreatic cancer	0.000318	0.00142	CbGpPWpGaD
Acamprosate—Tachycardia—Epirubicin—pancreatic cancer	0.000317	0.000408	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—SHH—pancreatic cancer	0.000317	0.00142	CbGpPWpGaD
Acamprosate—Skin disorder—Epirubicin—pancreatic cancer	0.000316	0.000406	CcSEcCtD
Acamprosate—GRIN1—Spinal Cord Injury—EGFR—pancreatic cancer	0.000315	0.00141	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—NOTCH4—pancreatic cancer	0.000315	0.00141	CbGpPWpGaD
Acamprosate—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000314	0.000404	CcSEcCtD
Acamprosate—Arthralgia—Doxorubicin—pancreatic cancer	0.000314	0.000404	CcSEcCtD
Acamprosate—Myalgia—Doxorubicin—pancreatic cancer	0.000314	0.000404	CcSEcCtD
Acamprosate—Chest pain—Doxorubicin—pancreatic cancer	0.000314	0.000404	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—IAPP—pancreatic cancer	0.000313	0.0014	CbGpPWpGaD
Acamprosate—Anxiety—Doxorubicin—pancreatic cancer	0.000312	0.000402	CcSEcCtD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000311	0.000401	CcSEcCtD
Acamprosate—Discomfort—Doxorubicin—pancreatic cancer	0.00031	0.000399	CcSEcCtD
Acamprosate—Anorexia—Epirubicin—pancreatic cancer	0.00031	0.000399	CcSEcCtD
Acamprosate—GRIN2D—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—pancreatic cancer	0.000308	0.00138	CbGpPWpGaD
Acamprosate—Dry mouth—Doxorubicin—pancreatic cancer	0.000307	0.000395	CcSEcCtD
Acamprosate—GRIN1—BDNF signaling pathway—SRC—pancreatic cancer	0.000306	0.00137	CbGpPWpGaD
Acamprosate—Vomiting—Docetaxel—pancreatic cancer	0.000306	0.000394	CcSEcCtD
Acamprosate—Rash—Docetaxel—pancreatic cancer	0.000304	0.000391	CcSEcCtD
Acamprosate—Hypotension—Epirubicin—pancreatic cancer	0.000304	0.000391	CcSEcCtD
Acamprosate—Dermatitis—Docetaxel—pancreatic cancer	0.000303	0.000391	CcSEcCtD
Acamprosate—GRIN1—EPH-Ephrin signaling—HRAS—pancreatic cancer	0.000303	0.00136	CbGpPWpGaD
Acamprosate—Confusional state—Doxorubicin—pancreatic cancer	0.000303	0.00039	CcSEcCtD
Acamprosate—Headache—Docetaxel—pancreatic cancer	0.000302	0.000389	CcSEcCtD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—HIF1A—pancreatic cancer	0.000301	0.00135	CbGpPWpGaD
Acamprosate—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000301	0.000387	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—PTCH1—pancreatic cancer	0.0003	0.00134	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PTHLH—pancreatic cancer	0.0003	0.00134	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—TNF—pancreatic cancer	0.0003	0.00134	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—SRC—pancreatic cancer	0.000299	0.00134	CbGpPWpGaD
Acamprosate—Infection—Doxorubicin—pancreatic cancer	0.000299	0.000385	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000296	0.000381	CcSEcCtD
Acamprosate—Shock—Doxorubicin—pancreatic cancer	0.000296	0.000381	CcSEcCtD
Acamprosate—GRIN2B—EPH-Ephrin signaling—HRAS—pancreatic cancer	0.000296	0.00132	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—STAT3—pancreatic cancer	0.000296	0.00132	CbGpPWpGaD
Acamprosate—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000294	0.000379	CcSEcCtD
Acamprosate—Insomnia—Epirubicin—pancreatic cancer	0.000294	0.000378	CcSEcCtD
Acamprosate—Tachycardia—Doxorubicin—pancreatic cancer	0.000293	0.000378	CcSEcCtD
Acamprosate—Skin disorder—Doxorubicin—pancreatic cancer	0.000292	0.000376	CcSEcCtD
Acamprosate—Paraesthesia—Epirubicin—pancreatic cancer	0.000292	0.000376	CcSEcCtD
Acamprosate—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000291	0.000374	CcSEcCtD
Acamprosate—Dyspnoea—Epirubicin—pancreatic cancer	0.00029	0.000373	CcSEcCtD
Acamprosate—Somnolence—Epirubicin—pancreatic cancer	0.000289	0.000372	CcSEcCtD
Acamprosate—GRIN2B—BDNF signaling pathway—STAT3—pancreatic cancer	0.000288	0.00129	CbGpPWpGaD
Acamprosate—Anorexia—Doxorubicin—pancreatic cancer	0.000287	0.000369	CcSEcCtD
Acamprosate—Nausea—Docetaxel—pancreatic cancer	0.000286	0.000368	CcSEcCtD
Acamprosate—Dyspepsia—Epirubicin—pancreatic cancer	0.000286	0.000368	CcSEcCtD
Acamprosate—GRIN1—Axon guidance—KDR—pancreatic cancer	0.000283	0.00127	CbGpPWpGaD
Acamprosate—Decreased appetite—Epirubicin—pancreatic cancer	0.000282	0.000364	CcSEcCtD
Acamprosate—Hypotension—Doxorubicin—pancreatic cancer	0.000281	0.000362	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.00028	0.000361	CcSEcCtD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—VEGFA—pancreatic cancer	0.00028	0.00125	CbGpPWpGaD
Acamprosate—Constipation—Epirubicin—pancreatic cancer	0.000278	0.000358	CcSEcCtD
Acamprosate—Pain—Epirubicin—pancreatic cancer	0.000278	0.000358	CcSEcCtD
Acamprosate—GRIN1—Axon guidance—MET—pancreatic cancer	0.000277	0.00124	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—KDR—pancreatic cancer	0.000276	0.00124	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—SST—pancreatic cancer	0.000275	0.00123	CbGpPWpGaD
Acamprosate—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000274	0.000353	CcSEcCtD
Acamprosate—Insomnia—Doxorubicin—pancreatic cancer	0.000272	0.00035	CcSEcCtD
Acamprosate—GRM5—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.000271	0.00121	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—MET—pancreatic cancer	0.00027	0.00121	CbGpPWpGaD
Acamprosate—Paraesthesia—Doxorubicin—pancreatic cancer	0.00027	0.000348	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—JAG1—pancreatic cancer	0.000269	0.0012	CbGpPWpGaD
Acamprosate—Dyspnoea—Doxorubicin—pancreatic cancer	0.000268	0.000345	CcSEcCtD
Acamprosate—Feeling abnormal—Epirubicin—pancreatic cancer	0.000268	0.000345	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—NOTCH3—pancreatic cancer	0.000268	0.0012	CbGpPWpGaD
Acamprosate—Somnolence—Doxorubicin—pancreatic cancer	0.000267	0.000344	CcSEcCtD
Acamprosate—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000266	0.000342	CcSEcCtD
Acamprosate—Dyspepsia—Doxorubicin—pancreatic cancer	0.000265	0.000341	CcSEcCtD
Acamprosate—GRIN1—Spinal Cord Injury—TP53—pancreatic cancer	0.000264	0.00118	CbGpPWpGaD
Acamprosate—Decreased appetite—Doxorubicin—pancreatic cancer	0.000261	0.000336	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.00026	0.000334	CcSEcCtD
Acamprosate—GRIN1—Developmental Biology—SMAD4—pancreatic cancer	0.000258	0.00116	CbGpPWpGaD
Acamprosate—Urticaria—Epirubicin—pancreatic cancer	0.000258	0.000332	CcSEcCtD
Acamprosate—Constipation—Doxorubicin—pancreatic cancer	0.000257	0.000331	CcSEcCtD
Acamprosate—Pain—Doxorubicin—pancreatic cancer	0.000257	0.000331	CcSEcCtD
Acamprosate—Body temperature increased—Epirubicin—pancreatic cancer	0.000257	0.000331	CcSEcCtD
Acamprosate—Abdominal pain—Epirubicin—pancreatic cancer	0.000257	0.000331	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—CNR1—pancreatic cancer	0.000253	0.00113	CbGpPWpGaD
Acamprosate—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—pancreatic cancer	0.000253	0.00113	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—HES1—pancreatic cancer	0.000252	0.00113	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—SMAD4—pancreatic cancer	0.000252	0.00113	CbGpPWpGaD
Acamprosate—GRIN2C—Transmission across Chemical Synapses—HRAS—pancreatic cancer	0.000249	0.00111	CbGpPWpGaD
Acamprosate—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000248	0.000319	CcSEcCtD
Acamprosate—GRM5—Signaling by GPCR—PIK3CG—pancreatic cancer	0.000246	0.0011	CbGpPWpGaD
Acamprosate—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000246	0.000317	CcSEcCtD
Acamprosate—GRIN2B—Developmental Biology—HES1—pancreatic cancer	0.000246	0.0011	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—GCG—pancreatic cancer	0.000245	0.0011	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—TNF—pancreatic cancer	0.00024	0.00107	CbGpPWpGaD
Acamprosate—Hypersensitivity—Epirubicin—pancreatic cancer	0.000239	0.000308	CcSEcCtD
Acamprosate—Urticaria—Doxorubicin—pancreatic cancer	0.000239	0.000308	CcSEcCtD
Acamprosate—GRM5—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.000238	0.00107	CbGpPWpGaD
Acamprosate—Abdominal pain—Doxorubicin—pancreatic cancer	0.000238	0.000306	CcSEcCtD
Acamprosate—Body temperature increased—Doxorubicin—pancreatic cancer	0.000238	0.000306	CcSEcCtD
Acamprosate—GABRB3—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	0.000237	0.00106	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—AGTR1—pancreatic cancer	0.000234	0.00105	CbGpPWpGaD
Acamprosate—Asthenia—Epirubicin—pancreatic cancer	0.000233	0.0003	CcSEcCtD
Acamprosate—GABRG2—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	0.000232	0.00104	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—CASP3—pancreatic cancer	0.000232	0.00104	CbGpPWpGaD
Acamprosate—GRIN2D—Transmission across Chemical Synapses—HRAS—pancreatic cancer	0.000232	0.00104	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—MMP2—pancreatic cancer	0.000231	0.00103	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—STK11—pancreatic cancer	0.00023	0.00103	CbGpPWpGaD
Acamprosate—Pruritus—Epirubicin—pancreatic cancer	0.00023	0.000296	CcSEcCtD
Acamprosate—GRIN2B—Axon guidance—MMP2—pancreatic cancer	0.000225	0.00101	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—CTNNB1—pancreatic cancer	0.000224	0.001	CbGpPWpGaD
Acamprosate—Diarrhoea—Epirubicin—pancreatic cancer	0.000222	0.000286	CcSEcCtD
Acamprosate—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000221	0.000285	CcSEcCtD
Acamprosate—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—pancreatic cancer	0.000221	0.000987	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—PIK3CD—pancreatic cancer	0.000216	0.000968	CbGpPWpGaD
Acamprosate—Asthenia—Doxorubicin—pancreatic cancer	0.000216	0.000278	CcSEcCtD
Acamprosate—GRIN1—BDNF signaling pathway—HRAS—pancreatic cancer	0.000216	0.000965	CbGpPWpGaD
Acamprosate—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—pancreatic cancer	0.000215	0.000962	CbGpPWpGaD
Acamprosate—Dizziness—Epirubicin—pancreatic cancer	0.000215	0.000277	CcSEcCtD
Acamprosate—Pruritus—Doxorubicin—pancreatic cancer	0.000213	0.000274	CcSEcCtD
Acamprosate—GRIN2B—BDNF signaling pathway—HRAS—pancreatic cancer	0.00021	0.000941	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—PIK3CB—pancreatic cancer	0.000208	0.000929	CbGpPWpGaD
Acamprosate—Vomiting—Epirubicin—pancreatic cancer	0.000207	0.000266	CcSEcCtD
Acamprosate—Diarrhoea—Doxorubicin—pancreatic cancer	0.000206	0.000265	CcSEcCtD
Acamprosate—Rash—Epirubicin—pancreatic cancer	0.000205	0.000264	CcSEcCtD
Acamprosate—Dermatitis—Epirubicin—pancreatic cancer	0.000205	0.000264	CcSEcCtD
Acamprosate—Headache—Epirubicin—pancreatic cancer	0.000204	0.000262	CcSEcCtD
Acamprosate—GABRA1—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	0.000203	0.000909	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—SRC—pancreatic cancer	0.000202	0.000905	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—KDR—pancreatic cancer	0.000202	0.000904	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—SMAD4—pancreatic cancer	0.000202	0.000902	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—CXCL8—pancreatic cancer	0.000199	0.000893	CbGpPWpGaD
Acamprosate—Dizziness—Doxorubicin—pancreatic cancer	0.000199	0.000256	CcSEcCtD
Acamprosate—GRIN1—Developmental Biology—MET—pancreatic cancer	0.000198	0.000885	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—KDR—pancreatic cancer	0.000197	0.000882	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—HES1—pancreatic cancer	0.000197	0.000881	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—CXCL8—pancreatic cancer	0.000195	0.000874	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—STAT3—pancreatic cancer	0.000195	0.000873	CbGpPWpGaD
Acamprosate—Nausea—Epirubicin—pancreatic cancer	0.000193	0.000248	CcSEcCtD
Acamprosate—GRIN2B—Developmental Biology—MET—pancreatic cancer	0.000193	0.000863	CbGpPWpGaD
Acamprosate—Vomiting—Doxorubicin—pancreatic cancer	0.000191	0.000246	CcSEcCtD
Acamprosate—GRIN2C—Neuronal System—HRAS—pancreatic cancer	0.000191	0.000854	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—AKT1—pancreatic cancer	0.00019	0.000852	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—NOTCH1—pancreatic cancer	0.00019	0.000852	CbGpPWpGaD
Acamprosate—GRIN2A—Transmission across Chemical Synapses—HRAS—pancreatic cancer	0.00019	0.000851	CbGpPWpGaD
Acamprosate—Rash—Doxorubicin—pancreatic cancer	0.00019	0.000244	CcSEcCtD
Acamprosate—Dermatitis—Doxorubicin—pancreatic cancer	0.000189	0.000244	CcSEcCtD
Acamprosate—GRM5—Signaling by GPCR—PIK3CB—pancreatic cancer	0.000189	0.000844	CbGpPWpGaD
Acamprosate—Headache—Doxorubicin—pancreatic cancer	0.000188	0.000242	CcSEcCtD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—CASP3—pancreatic cancer	0.000187	0.000836	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—AKT1—pancreatic cancer	0.000186	0.000831	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—NOTCH1—pancreatic cancer	0.000186	0.000831	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—CXCL8—pancreatic cancer	0.000181	0.000811	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—CTNNB1—pancreatic cancer	0.00018	0.000806	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—PPARG—pancreatic cancer	0.00018	0.000804	CbGpPWpGaD
Acamprosate—Nausea—Doxorubicin—pancreatic cancer	0.000179	0.00023	CcSEcCtD
Acamprosate—GRIN2D—Neuronal System—HRAS—pancreatic cancer	0.000177	0.000794	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—PPARG—pancreatic cancer	0.000175	0.000784	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—MMP9—pancreatic cancer	0.000174	0.000778	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—TERT—pancreatic cancer	0.000172	0.000772	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—MMP9—pancreatic cancer	0.000169	0.000758	CbGpPWpGaD
Acamprosate—GRIN1—Transmission across Chemical Synapses—HRAS—pancreatic cancer	0.000166	0.000742	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—HIF1A—pancreatic cancer	0.000165	0.000738	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—MMP2—pancreatic cancer	0.000165	0.000738	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—TSC2—pancreatic cancer	0.000165	0.000737	CbGpPWpGaD
Acamprosate—GRIN2B—Transmission across Chemical Synapses—HRAS—pancreatic cancer	0.000162	0.000724	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—APOE—pancreatic cancer	0.000161	0.000721	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—MMP2—pancreatic cancer	0.000161	0.00072	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—SRC—pancreatic cancer	0.00016	0.000717	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—VEGFA—pancreatic cancer	0.000159	0.00071	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—KDR—pancreatic cancer	0.000158	0.000706	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—SRC—pancreatic cancer	0.000156	0.000699	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—VEGFA—pancreatic cancer	0.000156	0.000698	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—NRAS—pancreatic cancer	0.000154	0.00069	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—VEGFA—pancreatic cancer	0.000152	0.000681	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—NRAS—pancreatic cancer	0.00015	0.000672	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—NFKBIA—pancreatic cancer	0.00015	0.000672	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—NOTCH1—pancreatic cancer	0.000149	0.000665	CbGpPWpGaD
Acamprosate—GRIN2A—Neuronal System—HRAS—pancreatic cancer	0.000146	0.000652	CbGpPWpGaD
Acamprosate—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—pancreatic cancer	0.000146	0.000651	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PIK3CG—pancreatic cancer	0.000145	0.000651	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—NRAS—pancreatic cancer	0.000145	0.00065	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—EGF—pancreatic cancer	0.000144	0.000643	CbGpPWpGaD
Acamprosate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—pancreatic cancer	0.000143	0.00064	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—HRAS—pancreatic cancer	0.000142	0.000637	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—EGFR—pancreatic cancer	0.00014	0.000628	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—EGFR—pancreatic cancer	0.000137	0.000613	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—TNF—pancreatic cancer	0.000136	0.000608	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—KRAS—pancreatic cancer	0.000133	0.000594	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—EGFR—pancreatic cancer	0.000132	0.000593	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—KRAS—pancreatic cancer	0.000129	0.000579	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PIK3CD—pancreatic cancer	0.000128	0.000572	CbGpPWpGaD
Acamprosate—GRIN1—Neuronal System—HRAS—pancreatic cancer	0.000127	0.000569	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—PIK3CA—pancreatic cancer	0.000127	0.000566	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—CTNNB1—pancreatic cancer	0.000126	0.000566	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—AKT1—pancreatic cancer	0.000126	0.000562	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—KRAS—pancreatic cancer	0.000125	0.00056	CbGpPWpGaD
Acamprosate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—pancreatic cancer	0.000125	0.000559	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—MMP9—pancreatic cancer	0.000124	0.000555	CbGpPWpGaD
Acamprosate—GRIN2B—Neuronal System—HRAS—pancreatic cancer	0.000124	0.000554	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—CTNNB1—pancreatic cancer	0.000123	0.000552	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—MMP9—pancreatic cancer	0.000121	0.000541	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—PIK3CA—pancreatic cancer	0.000115	0.000514	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—SRC—pancreatic cancer	0.000114	0.000512	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—HRAS—pancreatic cancer	0.000113	0.000505	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—SRC—pancreatic cancer	0.000111	0.000499	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PIK3CB—pancreatic cancer	0.000111	0.000498	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—VEGFA—pancreatic cancer	0.000111	0.000498	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—STAT3—pancreatic cancer	0.00011	0.000493	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—NRAS—pancreatic cancer	0.00011	0.000492	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—HRAS—pancreatic cancer	0.00011	0.000492	CbGpPWpGaD
Acamprosate—GABRB3—Transmission across Chemical Synapses—HRAS—pancreatic cancer	0.000109	0.00049	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—VEGFA—pancreatic cancer	0.000109	0.000486	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—STAT3—pancreatic cancer	0.000107	0.000481	CbGpPWpGaD
Acamprosate—GABRG2—Transmission across Chemical Synapses—HRAS—pancreatic cancer	0.000107	0.000481	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—NRAS—pancreatic cancer	0.000107	0.00048	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CXCL8—pancreatic cancer	0.000107	0.000479	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—HRAS—pancreatic cancer	0.000106	0.000476	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—AKT1—pancreatic cancer	0.000103	0.000463	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CASP3—pancreatic cancer	0.000102	0.000458	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—TGFB1—pancreatic cancer	0.000102	0.000457	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—EGFR—pancreatic cancer	0.0001	0.000448	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CCND1—pancreatic cancer	9.97e-05	0.000446	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—TGFB1—pancreatic cancer	9.96e-05	0.000446	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CTNNB1—pancreatic cancer	9.87e-05	0.000442	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—EGFR—pancreatic cancer	9.77e-05	0.000437	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MMP9—pancreatic cancer	9.68e-05	0.000433	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PTEN—pancreatic cancer	9.62e-05	0.000431	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—TNF—pancreatic cancer	9.54e-05	0.000427	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—KRAS—pancreatic cancer	9.46e-05	0.000424	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—HRAS—pancreatic cancer	9.39e-05	0.00042	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—AKT1—pancreatic cancer	9.39e-05	0.00042	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—TNF—pancreatic cancer	9.3e-05	0.000416	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—KRAS—pancreatic cancer	9.23e-05	0.000413	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—SRC—pancreatic cancer	8.92e-05	0.000399	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—VEGFA—pancreatic cancer	8.69e-05	0.000389	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—STAT3—pancreatic cancer	8.61e-05	0.000385	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—NRAS—pancreatic cancer	8.58e-05	0.000384	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—HRAS—pancreatic cancer	8.38e-05	0.000375	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—HRAS—pancreatic cancer	8.23e-05	0.000368	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—HRAS—pancreatic cancer	8.04e-05	0.00036	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MYC—pancreatic cancer	8e-05	0.000358	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—TGFB1—pancreatic cancer	7.98e-05	0.000357	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—HRAS—pancreatic cancer	7.84e-05	0.000351	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—EGFR—pancreatic cancer	7.82e-05	0.00035	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—KRAS—pancreatic cancer	7.39e-05	0.000331	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—HRAS—pancreatic cancer	7.19e-05	0.000322	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—AKT1—pancreatic cancer	7.1e-05	0.000318	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—AKT1—pancreatic cancer	6.92e-05	0.00031	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PIK3CA—pancreatic cancer	6.79e-05	0.000304	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—TP53—pancreatic cancer	6.57e-05	0.000294	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—HRAS—pancreatic cancer	6.28e-05	0.000281	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—AKT1—pancreatic cancer	5.55e-05	0.000248	CbGpPWpGaD
